These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28971860)

  • 81. Effect of combined low dose praziquantel and oxamniquine on different stages of schistosome maturity.
    Botros S; Soliman A; el-Gawhary N; Selim M; Guirguis N
    Trans R Soc Trop Med Hyg; 1989; 83(1):86-9. PubMed ID: 2513673
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Studies on the mode of action of oxamniquine and related schistosomicidal drugs.
    Pica-Mattoccia L; Cioli D
    Am J Trop Med Hyg; 1985 Jan; 34(1):112-8. PubMed ID: 3838223
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals.
    Utzinger J; Chollet J; You J; Mei J; Tanner M; Xiao S
    Acta Trop; 2001 Sep; 80(1):9-18. PubMed ID: 11495639
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Praziquantel--its use, cost and possible development of resistance.
    Kusel J; Hagan P
    Parasitol Today; 1999 Sep; 15(9):352-4. PubMed ID: 10461159
    [No Abstract]   [Full Text] [Related]  

  • 85. Pharmacological and immunological effects of praziquantel against Schistosoma japonicum: a scoping review of experimental studies.
    Xiao SH; Sun J; Chen MG
    Infect Dis Poverty; 2018 Feb; 7(1):9. PubMed ID: 29409536
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Overview on cysteine protease inhibitors as chemotherapy for Schistosomiasis mansoni in mice and also its effect on the parasitological and immunological profile.
    Farid A; Malek AA; Rabie I; Helmy A; El Amir AM
    Pak J Biol Sci; 2013 Dec; 16(24):1849-61. PubMed ID: 24517000
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Treatment of schistosomiasis mansoni with a combination of oxamniquine and praziquantel. I--Experimental observations related to the pre-patent phase].
    Campos R; Pinto PL; de Sant'Ana EJ; Moreira AA; Amato Neto V
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(5):201-3. PubMed ID: 3135570
    [No Abstract]   [Full Text] [Related]  

  • 88. Antischistosomal properties of aurone derivatives against juvenile and adult worms of Schistosoma mansoni.
    Pereira VRD; da Silveira LS; Mengarda AC; Alves Júnior IJ; da Silva OOZ; Miguel FB; Silva MP; Almeida ADC; Torres DDS; Pinto PF; Coimbra ES; de Moraes J; Couri MRC; da Silva Filho AA
    Acta Trop; 2021 Jan; 213():105741. PubMed ID: 33159900
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Alternate chemotherapy in experimental schistosomiasis.
    Ismail MM; Farghaly AM; Hassan MM; Youssef SM; Mohamed FE
    J Egypt Soc Parasitol; 1992 Aug; 22(2):321-6. PubMed ID: 1500769
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Effect of praziquantel treatment on lung-stage larvae of Schistosoma mansoni in vivo.
    Flisser A; McLaren DJ
    Parasitology; 1989 Apr; 98 Pt 2():203-11. PubMed ID: 2474788
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Antischistosomal and liver protective effects of Curcuma longa extract in Schistosoma mansoni infected mice.
    El-Ansary AK; Ahmed SA; Aly SA
    Indian J Exp Biol; 2007 Sep; 45(9):791-801. PubMed ID: 17907745
    [TBL] [Abstract][Full Text] [Related]  

  • 92. In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium.
    Kovač J; Vargas M; Keiser J
    Parasit Vectors; 2017 Aug; 10(1):365. PubMed ID: 28764732
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Dihydroartemisinin: a new story of an old drug against Schistosoma mansoni infection.
    Li HJ; Xu FL; Wang YH; Yi ZJ; Wang W
    Parasitol Res; 2014 Jan; 113(1):239-41. PubMed ID: 24146209
    [TBL] [Abstract][Full Text] [Related]  

  • 94.
    Cajas RA; Santos SSB; Espírito-Santo MCC; Garedaghi Y; de Moraes J
    Antimicrob Agents Chemother; 2024 Jul; 68(7):e0011424. PubMed ID: 38780260
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Detection of praziquantel resistance in schistosomes.
    Liang YS; Coles GC; Doenhoff MJ
    Trop Med Int Health; 2000 Jan; 5(1):72. PubMed ID: 10672208
    [No Abstract]   [Full Text] [Related]  

  • 96. Randomized comparative trials of single doses of the newer antischistosomal drugs at Mwanza, Tanzania. I. Praziquantel and oxamniquine for the treatment of schistosomiasis mansoni.
    Rugemalila JB; Asila J; Chimbe A
    J Trop Med Hyg; 1984 Dec; 87(6):231-5. PubMed ID: 6398833
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice.
    Van Nassauw L; Toovey S; Van Op den Bosch J; Timmermans JP; Vercruysse J
    Travel Med Infect Dis; 2008 Sep; 6(5):253-8. PubMed ID: 18760248
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Effect of oxamniquine on Schistosoma mansoni: some biological and biochemical observations.
    Goldberg M; Gold D; Flescher E; Lengy J
    Biochem Pharmacol; 1980 Mar; 29(5):838-40. PubMed ID: 20227968
    [No Abstract]   [Full Text] [Related]  

  • 99. Comparison between the efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infections on a sugar estate in Ethiopia.
    Taddese K; Zein ZA
    Ann Trop Med Parasitol; 1988 Apr; 82(2):175-80. PubMed ID: 3140748
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Dose-response relationship in Schistosoma mansoni juvenile and adult stages following limonin treatment in experimentally infected mice.
    Eraky MA; El-Kholy AA; Rashed GA; Hammam OA; Moharam AF; Abou-Ouf EA; Aly NS; Kishik SM; Abdallah KF; Hamdan DI
    Parasitol Res; 2016 Oct; 115(10):4045-54. PubMed ID: 27325399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.